Swiss Top Stock Picks from Analysts

TX Group

Market Cap: CHF 1.3b

Operates a network of platforms and participations that provides users with information, orientation, entertainment, and other services in Switzerland.

Cosmo

Market Cap: CHF 1.3b

A life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.

naturenergie holding

Market Cap: CHF 1.1b

Through its subsidiaries, engages in the production, distribution, and sale of electricity under the Naturenergie brand in Switzerland and internationally.

Kuros Biosciences

Market Cap: CHF 852.5m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

Basilea Pharmaceutica

Market Cap: CHF 660.7m

A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.

medmix

Market Cap: CHF 359.5m

Designs, produces, and sells high-precision devices and services in Switzerland and internationally.

CPH Group

Market Cap: CHF 346.5m

Develops, manufactures, and distributes chemical products and packaging solutions for pharmaceutical customers in Europe, Asia, and North and South America.

Newron Pharmaceuticals

Market Cap: CHF 281.0m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

Peach Property Group

Market Cap: CHF 277.7m

Engages in investment and development of residential real estate properties in Germany and Switzerland.

Mikron Holding

Market Cap: CHF 272.8m

Develops, produces, and markets automation solutions, machining systems, and cutting tools in the Switzerland, Europe, North America, the Asia Pacific, and internationally.

Santhera Pharmaceuticals Holding

Market Cap: CHF 218.1m

A specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.

BioVersys

Market Cap: CHF 157.9m

Researches and develops antimicrobial drugs for bacterial infections.

Varia US Properties

Market Cap: CHF 128.6m

A real estate investment company, acquires, holds, and sells properties in the United States.

lastminute.com

Market Cap: CHF 126.2m

Operates in the online travel industry providing dynamic holiday packages in the United Kingdom, Germany, France, Spain and Italy, and internationally.

Curatis Holding

Market Cap: CHF 123.2m

Engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases.

Xlife Sciences

Market Cap: CHF 122.3m

Focuses on the development and commercialization of research projects in the life sciences sector.

Molecular Partners

Market Cap: CHF 117.8m

A clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland.

MindMaze Therapeutics Holding

Market Cap: CHF 67.9m

Operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally.

Asmallworld

Market Cap: CHF 8.7m

Operates a digital travel and lifestyle ecosystem worldwide.